pharma
© Peter Scott

US pharma bosses are considering moving their production home, which could have far-reaching consequences for global pharma supply chains. The obstacles are challenging, though.

Last week pharma giant Eli Lilly announced plans to spend at least $27bn on the construction of four ...

Daily News from £12 / mo  ·  includes Daily News

Comment on this article


You must be logged in to post a comment.